Back to trial details

Intake questionnaire

Study of the Pharmacokinetics and Safety of Glecaprevir/Pibrentasvir Initiated in Pregnancy in Women With Hepatitis C With and Without HIV

Applying to David Geffen School of Medicine at UCLA · Los Angeles, California

Answer a few short questions to share with the research team.

0 of 4 answered

1. Are you between 16 and 45 years old?
2. Do you identify as female?
3. Have you been diagnosed with Hepatitis C?
4. Are you able to travel to Los Angeles for study visits?